Articles

COVER

• Advancements in MS Therapy

  New oral agents—approved and in the pipeline—may instigate an evolution in the treatment of MS.

  By Paul Winnington, Editorial Director

FEATURES

• EMG and Nerve Conduction Studies in Clinical Practice

  Electrodiagnostic studies are helpful in evaluating weakness, muscle wasting, and sensory symptoms. More specific questions may allow more detailed and directed conclusions.

  By Rossitza I. Chichkova, MD, MS and Lara Katzin, MD

• Case Report: Neurofibromatosis Involving the Fibula in an Adult Patient

  By Julieanne P. Sees, DO and Joseph N. Daniel, DO

DEPARTMENTS

• In The News

• Editor's Message

  By Pau Winnington, Editorial Director.

• Dementia Insights: OSA: Cognitive Consequences and Treatment of the Normal Population or those with AD

  There’s clear evidence of a link between sleep disturbance and cognitive function. A specialist explores implications for patient management.

  By Ronald Devere, MD

• Therapeutics Q&A: Abobotulinum Toxin in Clinical Practice

  The newest formulation of botulinum toxin type A expands the treatment menu.

  By Zac Haughn, Senior Associate Editor

• Expert Opinion: In Search of the Cerebral Funny Bone: Brain Deficits and Their Neuropsychological Correlates with Humor

  Trauma or other brain deficits can impact the patient’s ability to recognize and respond to humor.

  By Jessica Norman, MS, Joely P. Esposito, PsyD, Steven Mandel, MD, and Edward E. Maitz, PhD